Avient Corp.: Barclays initiates coverage with equal-weight rating and target price $44
AVNT•Barclays initiated coverage of Avient Corp. with an equal-weight rating and a $44 target price.
Related News
United Therapeutics presents preliminary PHINDER study data to develop PH-ILD screening tool at CHEST 2026
UTHR•
Aclarion to present at LD Micro Main Event XX
ACON•
Kimberly-Clark: TD Cowen cuts target price to $97 from $104
KMB•
InMode updates financial calendar, sets third-quarter 2026 results release date
INMD•
Vital Farms Inc: TD Cowen cuts target price to $8 from $11
VITL•